- Statins lower cholesterol levels through inhibition of HMG-CoA reductase.
- Although all statins go through hepatic metabolism, the elimination half-lives vary in length. Simvastatin, fluvastatin, and lovastatin have a short elimination half-life compared to other drugs within the class. Agents with significantly shorter elimination half-lives require bedtime dosing to maximize efficacy - allowing the greatest statin concentration to be present while endogenous cholesterol synthesis is the highest. Alternatively, the longer half-lives of rosuvastatin, atorvastatin, pitavastatin, and pravastatin allow these agents to maintain a therapeutic drug concentration over a 24-hour period and allow alternate administration times.
- LDL-C and TC lowering was significantly greater in the evening dose than in the morning dose in case of short-acting statins. Besides slight but significant effect on LDL-C, the efficacy of long-acting statins was equivalent for both regimens. Therefore, long-acting statins should be given at a time that will best aid compliance. Short-acting statins should be given in the evening.
- The half-life of atorvastatin is about 14 hours, while its active metabolites have a half-life of about 20 to 30 hours. Agents with longer half-lives allow for greater flexibility in administration time, which may improve compliance and ultimately result in greater LDL-C reduction and ability to achieve cholesterol goals.
- Simvastatin is a prodrug activated by first-pass hepatic metabolism to a hydroxyacid metabolite, which has a half-life of 1–2 hours.
Statin
|
Half-Life
|
Suggested Time of Administration
|
Lovastatin (Mevacor)
|
1.1 – 1.7
hours
|
Night
|
Simvastatin (Zocor)
|
3 hours
|
Night
|
Fluvastatin (Lescol)
|
IR: <3
hours
ER: 9
hours
|
Night
|
Pitavastatin (Livalo)
|
12 hours
|
Anytime
|
Atorvastatin (Lipitor)
|
Parent Drug:
14 hours
Metabolites:
20 – 30 hours
|
Anytime
|
Rosuvastatin (Crestor)
|
19 hours
|
Anytime
|
Pravastatin (Pravachol)
|
77 hours
|
Anytime
|
Table: Half-life and suggested
administration
Statin
|
Dosage
|
||
Low-intensity
(LDL-C reduction <30%) |
Moderate-intensity
(LDL-C reduction 30% to <50%) |
High-intensity
(LDL-C reduction >50%) |
|
Atorvastatin
|
NA
|
10 to 20
mg
|
40 to 80
mg
|
Fluvastatin
|
20 to 40
mg
|
40 mg
2×/day;
XL 80 mg
|
NA
|
Lovastatin
|
20 mg
|
40 mg
|
NA
|
Pitavastatin
|
1 mg
|
2 to 4 mg
|
NA
|
Pravastatin
|
10 to 20
mg
|
40 to 80
mg
|
NA
|
Rosuvastatin
|
NA
|
5 to 10
mg
|
20 to 40
mg
|
Simvastatin
|
10 mg
|
20 to 40
mg
|
NA
|
Table: Statin Dosing and ACC/AHA
Classification of Intensity, 2013
References:
1.
Awad, K., Serban, M.-C., Penson, P., Mikhailidis, D. P., Toth, P.
P., Jones, S. R., Rizzo, M., Howard, G., Lip, G. Y. H., &Banach, M. (2017).
Effects of morning vs evening statin administration on lipid profile: A
systematic review and meta-analysis. Journal of Clinical Lipidology, 11(4),
972–985.e9. https://doi.org/10.1016/j.jacl.2017.06.001
2.
Chou R, Dana T, Blazina I, et al. Statin Use for the Prevention of
Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive
Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research
and Quality (US); 2016 Nov. (Evidence Syntheses, No. 139.) Table 1, Statin
Dosing and ACC/AHA Classification of Intensity. Available from: https://www.ncbi.nlm.nih.gov/books/NBK396417/table/ch1.t1/
3.
Plakogiannis, R., & Cohen, H. (2007).
Optimal low-density lipoprotein cholesterol lowering--morning versus evening
statin administration. The Annals of pharmacotherapy, 41(1),
106–110. https://doi.org/10.1345/aph.1G659
4.
Which Statin Is the Best Choice for Which Patient? (2014). American
Family Physician, 65(6), 1211. https://www.aafp.org/afp/2002/0315/p1211.html
5.
(n.d.). Statin Dose Intensity and Equivalency Chart [Review
of Statin Dose Intensity and Equivalency Chart]. UMHS Lipid Therapy
Guideline. http://www.mqic.org/pdf/UMHS_Statin_Dose_Intensity_and_Equivalency_Chart.pdf
All information accessed on 17 July 2020
[Prepared by Noratikah ; Edited by JCK Ho]
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.